BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6544590)

  • 1. Mass-spectrometry determination of urinary catecholamine metabolites children with neuroblastoma.
    Lucarelli C; Boniforti L; Castello MA; Clerico A
    Ann Ist Super Sanita; 1983; 19(4):655-9. PubMed ID: 6544590
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
    Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
    Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secretion of ibuprofen metabolites interferes with the capillary chromatography of urinary homovanillic acid and 4-hydroxy-3-methoxymandelic acid in neuroblastoma diagnosis.
    Levreri I; Caruso U; Deiana F; Buoncompagni A; De Bernardi B; Marchese N; Melioli G
    Clin Chem Lab Med; 2005; 43(2):173-7. PubMed ID: 15843212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
    Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
    J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
    Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis.
    Fitzgibbon MC; Tormey WP
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():1-11. PubMed ID: 8154845
    [No Abstract]   [Full Text] [Related]  

  • 7. N-myc oncogene amplification and catecholamine metabolism in children with neuroblastoma.
    Nakagawara A; Ikeda K
    Lancet; 1987 Mar; 1(8532):559. PubMed ID: 2881101
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA ploidy in neuroblastoma.
    Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
    Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of catecholamine metabolites in urine by mass fragmentography with application to diagnostic examination.
    Bando K; Hayashi C; Miyai K
    Med J Osaka Univ; 1981 Mar; 31(3-4):101-10. PubMed ID: 7311911
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation and determination of urinary homovanillic acid and iso-homovanillic acid by gas-liquid chromatography and electron capture detection.
    Dziedzic SW; Dziedzic LB; Gitlow SE
    J Lab Clin Med; 1973 Nov; 82(5):829-35. PubMed ID: 4746822
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal urinary excretion of catecholamine catabolites in children with retinoblastoma.
    Orlowski JP; Levin HS; Price RL; Dyment PG
    Med Pediatr Oncol; 1978; 4(4):343-9. PubMed ID: 723798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of dopamine, HVA and HMMA in untimed urine samples: establishment of age-related reference data in children.
    Henderson MJ; Heney D; McGinlay JM; Lewis I; Bailey C
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():162-7. PubMed ID: 1626919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of random urinary catecholamines and their metabolites in neuroblastoma.
    O'Meara A; Tormey W; FitzGerald RJ; Fitzgibbon M; Kenny D
    Acta Paediatr; 1994 Jan; 83(1):88-92. PubMed ID: 8193481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography: applications in a children's hospital.
    Soldin SJ
    Adv Chromatogr; 1982; 20():139-66. PubMed ID: 6293278
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the determination of serum catecholamine metabolites in the early diagnosis of neuroblastoma].
    Shi YQ
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):150-1. PubMed ID: 3111662
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological, immunohistochemical, and chromosomal studies on non-adrenal neuroblastomas without increased excretion of catecholamines and their metabolites in urine.
    Sakatoku H; Komada Y; Hamazaki Y; Kamiya H; Sakurai M
    Med Pediatr Oncol; 1990; 18(6):491-6. PubMed ID: 2233522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical monitoring of children with neuroblastoma.
    Abeling NG; van Gennip AH; Overmars H; Voûte PA
    Radiother Oncol; 1986 Sep; 7(1):27-35. PubMed ID: 3095895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
    Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
    Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.